New Insights into the Pathophysiology and Treatment of Non-Cystic Fibrosis Bronchiectasis

Program Overview

Panel Discussion

This 30-minute interactive panel discussion with an interprofessional clinical expert panel and an experienced patient with non-cystic fibrosis bronchiectasis (NCFBE) will focus on disease burden, symptom recognition, diagnosis, immunopathology, and emerging therapies for patients with NCFBE.

Link to Module 1

Link to Module 2

Credit Expired

Target Audience

Pulmonology, infectious diseases, primary care, and radiology clinicians managing patients with NCFBE

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify the impact of non-cystic fibrosis bronchiectasis (NCFBE) and its exacerbations on patient quality of life
Utilize clinical practice guidelines for NCFBE diagnosis
Examine emerging treatments targeting the underlying immune-mediated pathophysiologic processes of NCFBE
Integrate the unique roles and responsibilities of the interprofessional care team when diagnosing and treating patients with NCFBE

Activity Faculty

Mark L. Metersky, MD, FCCP

Professor, Medicine
Associate Chief of Service, Department of Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Director, Center for Bronchiectasis Care
UConn Health
Farmington, CT

Margaret M. Johnson, MD

Professor, Medicine
Mayo Clinic College of Medicine and Science
Consultant, Pulmonary Medicine
Mayo Clinic
Jacksonville, FL

Molly Mailes, MSN, RN, MEDSURG-BC

Nurse Program Coordinator, Adult Cystic Fibrosis
Mayo Clinic
Jacksonville, FL

Resources

Featured RMEI CE Activities – Earn CE Credit(s)

New Insights into the Pathophysiology and Treatment of Non-Cystic Fibrosis Bronchiectasis

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Mark L. Metersky, MD, FCCP

Margaret M. Johnson, MD

Molly Mailes, MSN, RN, MEDSURG-BC

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe